RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ANI Pharmaceuticals - Stock

ANI Pharmaceuticals Market capitalization 2024

ANI Pharmaceuticals Market capitalization

1.16 B USD

Ticker

ANIP

ISIN

US00182C1036

WKN

A1W15D

In 2024, ANI Pharmaceuticals's market cap stood at 1.16 B USD, a 25.17% increase from the 925.64 M USD market cap in the previous year.

The ANI Pharmaceuticals Market capitalization history

YEARREVENUE (undefined USD)GROSS MARGIN (%)NET INCOME (undefined USD)
2029e707.8343,13146.88
2028e680.2244,88147.3
2027e654.1146,67130.91
2026e625.3548,82119.35
2025e590.251,73106.64
2024e553.4655,1695.91
2023486.8262,7115.48
2022316.456,13-49.5
2021216.153,45-42.8
2020208.558,18-22.5
2019206.569,446
2018201.663,7915.3
2017176.855,32-1.1
2016128.662,053.9
201576.383,3615.3
20145679,4628.6
201330.166,78-4.7
201220.454,90-8.4
20110.4100,00-51.6
20102.588,00-46.2
20091.376,92-47.5
20083.878,95-17.4
20070.5100,00-7.6
200614.475,692.8
20050.3100,00-9.7
20040.1-500,00-12

ANI Pharmaceuticals Aktienanalyse

What does ANI Pharmaceuticals do?

The company ANI Pharmaceuticals Inc was founded in 2001 and is located in Baudette, Minnesota, USA. ANI Pharmaceuticals is a pharmaceutical company specialized in the development and manufacturing of generic, branded, and biosimilar drugs, as well as novel therapeutic products for a wide range of diseases. ANI Pharmaceuticals has earned a good reputation over the years as a reliable provider of medications for well-known medical conditions. The company specializes in the production of prescription drugs for various conditions, including central nervous system disorders, infectious diseases, cardiovascular diseases, pain, and attention deficit/hyperactivity disorders. ANI Pharmaceuticals' business model is to provide its customers with high-quality, cost-effective, and innovative drugs. The company has an extensive portfolio of products that includes both generics and branded drugs. The company has also specialized in the production of biosimilars - bioproducts that mimic biological drugs whose patent protection has expired. ANI Pharmaceuticals pursues a differentiation strategy to strengthen its competitive position through innovative products, brand building, quality control, and cost leadership. For example, in 2019, the company developed Exservan, a liquid treatment for amyotrophic lateral sclerosis (ALS) that patients can take daily through an enlarged mouth opening. ANI Pharmaceuticals has various business segments: - Generics Business: ANI Pharmaceuticals manufactures a variety of generics for various diseases, including drugs for Parkinson's disease, pain, hypertension, and antidepressants. - Branded Product Business: ANI Pharmaceuticals also markets its own portfolio of branded products, mainly based on critical medical needs. These include Inversine - an oral medication for hypertension, Lithium Carbonate - a medication for mood disorders, and Inderal - a medication for cardiovascular diseases. - Contract Manufacturing Business: ANI Pharmaceuticals also offers contract manufacturing services for other pharmaceutical companies. ANI Pharmaceuticals provides a range of development and manufacturing services, including process development, formulation development, scale-up, validation, packaging, and distribution. - Biosimilars Business: ANI Pharmaceuticals specializes in the production of biosimilars and is working on the development of biological replicas of drugs whose patent protection has expired. This allows patients to receive a more cost-effective alternative treatment. Overall, ANI Pharmaceuticals has a strong focus on manufacturing cost-effective and high-quality medications for patients and healthcare facilities. The company has an excellent product range and is well positioned to offer innovative and highly effective drugs for the treatment of diseases in the future. ANI Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring ANI Pharmaceuticals's Market Capitalization

ANI Pharmaceuticals's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of ANI Pharmaceuticals's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

ANI Pharmaceuticals's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in ANI Pharmaceuticals’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about ANI Pharmaceuticals Stock

What is the current ANI Pharmaceuticals market capitalization?

The current market capitalization of ANI Pharmaceuticals is 1.16 B USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like ANI Pharmaceuticals.

How has the market capitalization of ANI Pharmaceuticals developed in recent years?

The market capitalization of ANI Pharmaceuticals has increased/decreased by 25.17% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of ANI Pharmaceuticals?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of ANI Pharmaceuticals?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of ANI Pharmaceuticals have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does ANI Pharmaceuticals pay?

Over the past 12 months, ANI Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ANI Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of ANI Pharmaceuticals?

The current dividend yield of ANI Pharmaceuticals is .

When does ANI Pharmaceuticals pay dividends?

ANI Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ANI Pharmaceuticals?

ANI Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of ANI Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ANI Pharmaceuticals located?

ANI Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von ANI Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ANI Pharmaceuticals from 7/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.

When did ANI Pharmaceuticals pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of ANI Pharmaceuticals in the year 2023?

In the year 2023, ANI Pharmaceuticals distributed 0 USD as dividends.

In which currency does ANI Pharmaceuticals pay out the dividend?

The dividends of ANI Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The ANI Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von ANI Pharmaceuticals

Our stock analysis for ANI Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ANI Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.